Vimarsana
Biggest News Aggregation in the World

Total Back News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Total Back. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Total Back Today - Breaking & Trending Today

AbbVie's RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis - Vimarsana News

AbbVie's RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis

Published: October 7, 2021

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from the first of two studies of the Phase 3 SELECT-AXIS 2 clinical trial...

Source: prnewswire.com
Related Topics:
Michael SeverinoEuropean CommissionDrug AdministrationExchange CommissionSpondyloarthritis Research Consortium Of CanadaAssessment In Spondyloarthritis International SocietyAbbvie Deutschland Gmbh CoSpondyloarthritis International SocietyAnkylosing SpondylitisDisease ActivityLow Disease ActivityMagnetic Resonance ImagingSpondyloarthritis Research ConsortiumTotal Back PainBath Ankylosing Spondylitis Functional IndexEfficacy ResultsTotal BackAxial SpondyloarthritisImportant Safety Information AboutAllergan AestheticsPrivate Securities Litigation Reform ActQuarterly ReportsPsoriatic ArthritisInadequate ResponseWeek Data
AbbVie's Upadacitinib (RINVOQ®) Met Primary and Most Ranked Secondary Endpoints in Phase 3 Study for Non-Radiographic Axial Spondyloarthritis - Vimarsana News

AbbVie's Upadacitinib (RINVOQ®) Met Primary and Most Ranked Secondary Endpoints in Phase 3 Study for Non-Radiographic Axial Spondyloarthritis

Published: October 7, 2021

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from Study 2 of the Phase 3 SELECT-AXIS 2 clinical trial in adults with active...

Source: prnewswire.com
Related Topics:
Michael SeverinoEuropean CommissionDrug AdministrationExchange CommissionAssessment In Spondyloarthritis International SocietyAbbvie Deutschland Gmbh CoSpondyloarthritis International SocietyAnkylosing SpondylitisDisease ActivityLow Disease ActivityEfficacy ResultsMagnetic Resonance ImagingTotal BackAxial SpondyloarthritisImportant Safety Information AboutAllergan AestheticsPrivate Securities Litigation Reform ActQuarterly ReportsPsoriatic ArthritisInadequate ResponseWeek DataRandomized Controlled PhaseVie Deutschland GmbhEvaluate EfficacyAdult Participants With Axial Spondyloarthritis